DERMAXON, LLC

Basic Information

6610 JUSTIN CT
MISSOULA, MT, 59803-2969

Company Profile

n/a

Additional Details

Field Value
DUNS: 078771732
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: Y
Number of Employees: 2


  1. Inhibition of retinoic acid metabolism for reversal of cognitive deficits in AD

    Amount: $225,000.00

    DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is a progressive and ultimately fatal neurodegenerative disease that affects more than five million people in the USA. Currently ther ...

    STTR Phase I 2013 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government